The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 228.00
Bid: 226.00
Ask: 228.50
Change: 1.00 (0.44%)
Spread: 2.50 (1.106%)
Open: 227.00
High: 229.00
Low: 225.00
Prev. Close: 227.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

17 Feb 2023 17:00

RNS Number : 0752Q
PureTech Health PLC
17 February 2023
 

 

PDMR DEALING NOTIFICATION

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Dr. John LaMattina

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

PureTech Health plc

b)

LEI

213800LVPDNO2Z9T9I39

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of PureTech Health plc

ISIN GB00BY2Z0H74

b)

Nature of the transaction

A transfer of Ordinary Shares for nil consideration from Dr. LaMattina to a Schwab Charitable Fund affiliated with Dr. LaMattina.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

33,595

d)

Aggregated information

-

Aggregated volume

-

Price

 

Price

Aggregate Volume

Nil

33,595

e)

Date of the transaction

14 February 2023

f)

Place of the transaction

Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFELLFXLLBBBX
Date   Source Headline
18th Nov 202112:10 pmRNSPRTC's Gelesis Receives $30M Plenity Order from Ro
16th Nov 202112:00 pmRNSPRTC Publishes Previous LYT-100 MAD Study Results
15th Nov 202112:00 pmRNSPRTC Presents at Two Upcoming Investor Conferences
12th Nov 202112:00 pmRNSPRTC Presents Immunooncology Ph 1/2 Trial at SITC
11th Nov 202112:00 pmRNSFDA Grants PRTC's LYT-200 Orphan Drug Designation
10th Nov 20217:00 amRNSPRTC Receives $100M from Founded Entity Shares
9th Nov 202112:34 pmRNSKRTX and Zai Lab to Develop KarXT in Greater China
9th Nov 20217:00 amRNSPRTC Presents at Jefferies Healthcare Conference
1st Nov 202110:20 amRNSNew Research in Journal Nature on Gelesis Tech
1st Nov 20217:00 amRNSTotal Voting Rights
22nd Oct 20216:00 pmRNSHoldings in Company - TR-1 Correction Announcement
20th Oct 20214:35 pmRNSPrice Monitoring Extension
14th Oct 202112:01 pmRNSPRTC's Vedanta Appoints Chief Legal Officer
12th Oct 20217:00 amRNSAdditional Listing
5th Oct 20211:01 pmRNSVedanta Positive Phase 2 Data in C. Diff Infection
5th Oct 20211:00 pmRNSPRTC's Sonde Launches Mental Health Monitor
29th Sep 20211:01 pmRNSAkili/Shionogi Report Positive Ph2 Data in Japan
20th Sep 20214:02 pmRNSNew PureTech Research Published In Nature Journal
14th Sep 202112:00 pmRNSPRTC to Present at Oppenheimer Healthcare Summit
1st Sep 20217:00 amRNSTotal Voting Rights
24th Aug 20217:00 amRNSHalf-year Report
23rd Aug 202112:00 pmRNSPRTC Presents LYT-100 Ph1 PK & Tolerability at ERS
17th Aug 20211:03 pmRNSAkili Deal Furthers Digital Medicine Leadership
13th Aug 202112:00 pmRNSPRTC Appoints Industry Veteran & Physician as CMO
11th Aug 202112:00 pmRNSPRTC Receives $6.5M; Imbrium to Develop LYT-503
3rd Aug 20217:00 amRNSNotice of Results
2nd Aug 20217:00 amRNSTotal Voting Rights
23rd Jul 20217:00 amRNSPDMR DEALING - PURCHASE OF SHARES
22nd Jul 20211:03 pmRNSPRTC’s Akili Releases New Features for EndeavorRx
22nd Jul 20217:00 amRNSPDMR DEALING - PURCHASE OF SHARES
21st Jul 202112:03 pmRNSPureTech’s Vedanta Raises $68M Series D Financing
19th Jul 202112:02 pmRNSPRTC’s Gelesis to Become Public Via Capstar SPAC
9th Jul 202112:00 pmRNSPRTC’s Vor Announces Collaboration with Janssen
8th Jul 20212:05 pmRNSPRTC’s Sonde Announces Collaboration With Qualcomm
7th Jul 202112:00 pmRNSPRTC BeiGene LYT-200 Clinical Trial Agreement
1st Jul 20217:00 amRNSTotal Voting Rights
30th Jun 202112:00 pmRNSPRTC’s Vedanta Announces New Data from IBD Study
28th Jun 20217:00 amRNSPDMR DEALING - PURCHASE OF SHARES
24th Jun 20217:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Jun 20211:28 pmRNSKaruna Announces KarXT Results in Healthy Elderly
16th Jun 202112:00 pmRNSPureTech Acquires Alivio and Oral IL-22 Candidate
2nd Jun 20217:00 amRNSPDMR Notification RSU Vesting
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20216:16 pmRNSResult of AGM
27th May 20212:50 pmRNSPureTech’s Gelesis Presents Plenity Data at AACE
26th May 20211:05 pmRNSPureTech’s Akili Secures $160M in Financing
25th May 202112:00 pmRNSPRTC Presents at Jefferies Healthcare Conference
12th May 202112:00 pmRNSPureTech Forms IPF Clinical Advisory Board
28th Apr 20214:08 pmRNSNew PureTech Research Published in Nature Journal
26th Apr 20211:05 pmRNSGelesis Appoints Procter & Gamble Veteran to BOD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.